Carson Advisory Inc. Royalty Pharma PLC Transaction History
Carson Advisory Inc.
- $135 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
440Shares Held
295MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.28 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$743 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$548 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$456 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...